.ANALYSIS HIGHLIGHT.06 August 2024.
A large randomized controlled test with cisgender girls highlights the problems of faithfulness to a daily oral preexposure prophylaxis routine as well as shows that twice-yearly treatment of lenacapavir may preserve helpful HIV prevention degrees over 6 months.